In order to explore the longitudinal change in CDC42 and its correlation with treatment efficacy in RA patients, multiple-time measurements (at W0, W6, and W12 after the initiation of treatment) of CDC42 were conducted in our study. Here, CDC42 is linked to rheumatoid arthritis.